Psychiatry and Neurology, Neurology · Hamilton, NJ
NPI
1356449177
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
6
Medicare group memberships
Hospitals
5
Hospital affiliations
396 Whitehorse Ave
Hamilton, NJ, 08610
Phone (609) 585-0118
Groups this clinician bills Medicare through
Medicare paid, 2024
$137K
1,395 services
Medicare patients, 2024
677
Average age 75
Drug cost, 2024
$2.9M
4,673 prescriptions
Company payments, 2025
$1,487
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James A Ware Jr. was code 99214 (office e&m - established), 307 times for 180 patients. In total James A Ware Jr. billed 1,395 services in 23 codes, and Medicare paid $137K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 307 | 180 | $97.23 | $30K |
| 99232 Hospital E&M - Subsequent | Facility | 297 | 173 | $62.40 | $19K |
| 99223 Hospital E&M - Initial | Facility | 264 | 249 | $137.68 | $36K |
| 99233 Hospital E&M - Subsequent | Facility | 135 | 93 | $93.21 | $13K |
| 99213 Office E&M - Established | Office | 109 | 77 | $63.11 | $6,879 |
| 99204 Office E&M - New | Office | 40 | 40 | $119.76 | $4,790 |
| 99222 Hospital E&M - Initial | Facility | 30 | 30 | $99.42 | $2,983 |
| 95816 Neurologic | Facility | 27 | 25 | $44.84 | $1,211 |
| 99215 Office E&M - Established | Office | 27 | 22 | $145.67 | $3,933 |
| 99215 Office E&M - Established | Facility | 25 | 24 | $113.55 | $2,839 |
| 99205 Office E&M - New | Facility | 16 | 16 | $142.63 | $2,282 |
| 99204 Office E&M - New | Facility | 14 | 14 | $104.58 | $1,464 |
By year: 2022 $111K for 1,121 services; 2023 $111K for 1,114 services; 2024 $137K for 1,395 services.
Medicare prescription drug claims, 2024
In 2024, the drug James A Ware Jr. prescribed most often to Medicare patients was Memantine Hcl, with 308 prescriptions and refills. In total James A Ware Jr. wrote 4,673 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 308 | 471 | 64 | $5,930 |
| Gabapentin Generic | 297 | 435 | 60 | $3,756 |
| Topiramate Generic | 185 | 308 | 27 | $1,602 |
| Alprazolam Generic | 115 | 117 | 24 | $977 |
| Duloxetine Hcl Generic | 112 | 159 | 25 | $988 |
| Lacosamide Generic | 109 | 121 | 13 | $6,856 |
| Levetiracetam Generic | 93 | 158 | 18 | $3,613 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 91 | 141 | 19 | $2,536 |
| Escitalopram Oxalate Generic | 78 | 112 | 13 | $437 |
| Oxycodone Hcl Generic | 74 | 74 | Under 11 | $1,700 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 72 | 72 | Under 11 | $1,773 |
| Primidone Generic | 71 | 111 | 14 | $1,936 |
| Tizanidine Hcl Generic | 68 | 84 | 14 | $1,103 |
| Diazepam Generic | 68 | 74 | 17 | $639 |
| Cyclobenzaprine Hcl Generic | 67 | 80 | 24 | $513 |
Brand drugs: 787 claims; generic drugs: 3,865 claims; opioid claims: 287.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James A Ware Jr. $1,487 ($1,487 in general payments such as food, travel and fees) from 31 companies. The largest payer was Abbvie Inc. with $202.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 16 | $202 |
| Pfizer Inc. PFE | 15 | $170 |
| Neurocrine BioSciences, Inc. NBIX | 6 | $123 |
| CSL Behring CSL.AX | 2 | $72.38 |
| Alexion Pharmaceuticals, Inc. AZN | 4 | $70.27 |
| Alpha Cognition USA, Inc. ACOG | 1 | $67.18 |
| Axsome Therapeutics, Inc. AXSM | 3 | $64.51 |
| EMD Serono, Inc. MRK.DE | 3 | $56.88 |
| Octapharma USA, Inc. | 3 | $50.67 |
| Teva Pharmaceuticals USA, Inc. TEVA | 3 | $50.05 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.